US equities |
MU $1,045.56 ▲+0.00% INTC $112.50 ▲+0.00% NVDA $239.24 ▲+0.00% SNDK $1,660.46 ▲+0.00% SPCX $171.92 ▲+0.00% AMD $649.42 ▲+0.00% MRVL $287.01 ▲+0.00% AVGO $375.81 ▲+0.00%
FinancialContent

Articles published by BiogenEisai

News headline image
Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease in the New England Journal of Medicine
From BiogenEisai
Via JCN Newswire
Tickers ESALY